Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease
Jiashu Pan, Wenjun Zhou, Ruohui Xu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113127-113127
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Hepatology (2023) Vol. 15, Iss. 2, pp. 180-200
Open Access | Times Cited: 44
Per- and Polyfluoroalkyl Substances (PFASs) Impair Lipid Metabolism in Rana nigromaculata: A Field Investigation and Laboratory Study
Huikang Lin, Zhiquan Liu, Hongmei Yang, et al.
Environmental Science & Technology (2022) Vol. 56, Iss. 18, pp. 13222-13232
Closed Access | Times Cited: 62
Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation
Yan Zhang, Xueying Zhang, Shan-Rui Shi, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 11
Novel Thiazolones for the Simultaneous Modulation of PPARγ, COX-2 and 15-LOX to Address Metabolic Disease-associated Portal Inflammation
Mai S. El-Shoukrofy, Azza Ismail, Reem H. Elhamammy, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117415-117415
Open Access | Times Cited: 1
Perfluorohexanesulfonic Acid (PFHxS) Impairs Lipid Homeostasis in Zebrafish Larvae through Activation of PPARα
Ying‐Jie He, Haolin Liao, Ge Yang, et al.
Environmental Science & Technology (2024) Vol. 58, Iss. 37, pp. 16258-16268
Closed Access | Times Cited: 6
N-acetyl Cysteine Overdose Induced Acute Toxicity and Hepatic Microvesicular Steatosis by Disrupting GSH and Interfering Lipid Metabolisms in Normal Mice
Ming‐Shiun Tsai, Gunn‐Guang Liou, Jiunn‐Wang Liao, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 832-832
Open Access | Times Cited: 5
Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Sevag Hamamah, Oana C. Iatcu, Mihai Covașă
Nutrients (2024) Vol. 17, Iss. 1, pp. 143-143
Open Access | Times Cited: 4
The Many Facets of PPAR-γ Agonism in Obesity and Associated Comorbidities: Benefits, Risks, Challenges, and Future Directions
Dimitris Kounatidis, Natalia G. Vallianou, Eleni Rebelos, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Closed Access
Hawthorn total flavonoids ameliorate hyperlipidemia through AMPK/SREBP1‐c and PPARα/PGC‐1α/CPT‐1A pathway activation and gut microbiota modulation
Liping Zheng, Zhihao Lü, Yurong Ma, et al.
Journal of the Science of Food and Agriculture (2025)
Open Access
Damiana ( Turnera diffusa ) Reduces Adipocyte Cell Differentiation and Ameliorates Myocyte Glucose Uptake
Hee‐Sung Chae, Nova Ahmed, Olivia R. Dale, et al.
Journal of Dietary Supplements (2025), pp. 1-16
Closed Access
A novel Alisma orientale extract alleviates non-alcoholic steatohepatitis in mice via modulation of PPARα signaling pathway
Yan Xie, Yimin Jin, Jianhui Wen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116908-116908
Open Access | Times Cited: 3
Current and experimental pharmacotherapy for the management of non-alcoholic fatty liver disease
Angeliki Katsarou, Georgios Tsioulos, Eva Kassi, et al.
HORMONES (2024) Vol. 23, Iss. 4, pp. 621-636
Closed Access | Times Cited: 3
Carthamus tinctorius L. (Safflower) Flower Extract Attenuates Hepatic Injury and Steatosis in a Rat Model of Type 2 Diabetes Mellitus via Nrf2-Dependent Hypoglycemic, Antioxidant, and Hypolipidemic Effects
Nuha Saad Alshareef, Sahar Abdulaziz AlSedairy, Laila Naif Al‐Harbi, et al.
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1098-1098
Open Access | Times Cited: 3
Loss of endothelial glucocorticoid receptor accelerates organ fibrosis in db/db mice
Swayam Prakash Srivastava, Julie E. Goodwin
AJP Renal Physiology (2023) Vol. 325, Iss. 4, pp. F519-F526
Open Access | Times Cited: 8
Hypothalamic JNK1-hepatic fatty acid synthase axis mediates a metabolic rewiring that prevents hepatic steatosis in male mice treated with olanzapine via intraperitoneal: Additional effects of PTP1B inhibition
Vítor Ferreira, Cintia Folgueira, María García‐Altares, et al.
Redox Biology (2023) Vol. 63, pp. 102741-102741
Open Access | Times Cited: 5
Terminalia catappa Leaf Abrogates Diabetes-induced Dyslipidaemia in Type 2 Diabetic Rats by Upregulating Lipid Metabolic Genes
Franklyn Nonso Iheagwam, Olawumi Toyin Iheagwam, Olubanke Olujoke Ogunlana, et al.
Gene Expression (2023) Vol. 22, Iss. 3, pp. 167-182
Open Access | Times Cited: 5
C Allele of the PPARδ+294T>C Polymorphism Confers a Higher Risk of Hypercholesterolemia, but not Obesity and Insulin Resistance: A Systematic Review and Meta-Analysis
Shujin Li, Youjin Zhang, W. Xu, et al.
Hormone and Metabolic Research (2023) Vol. 55, Iss. 05, pp. 355-366
Closed Access | Times Cited: 4
Prebiotics Together with Raspberry Polyphenolic Extract Mitigate the Development of Nonalcoholic Fatty Liver Diseases in Zucker Rats
Bartosz Fotschki, Michał Sójka, Monika Kosmala, et al.
Nutrients (2023) Vol. 15, Iss. 14, pp. 3115-3115
Open Access | Times Cited: 4
Comparison of the anti-inflammatory and antilipidemic activity of diosmin and saroglitazar in a model of nonalcoholic fatty liver induced by a high-fat diet in Wistar rats.
Reza Afarin, Negar Dinarvand, Bahar Jaberian Asl, et al.
PubMed (2024) Vol. 27, Iss. 2, pp. 241-246
Closed Access | Times Cited: 1
Proteomic study of gamma-oryzanol preventive effect on a diet-induced non-alcoholic fatty liver disease model
Juliana Silva Siqueira, Jéssica Leite Garcia, Artur Júnio Togneri Ferron, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 127, pp. 109607-109607
Closed Access | Times Cited: 1
Exposure to Benzo(a)pyrene Enhances Acetaminophen-Induced Liver Injury in Mice at Non-Hepatotoxic Doses
Y. P., Jesús Olivero‐Verbel
Scientia Pharmaceutica (2024) Vol. 92, Iss. 2, pp. 30-30
Open Access | Times Cited: 1
Identification of an alternative ligand‐binding pocket in peroxisome proliferator‐activated receptor gamma and its correlated selective agonist for promoting beige adipocyte differentiation
Qiang Tian, Miaohua Wang, Xueting Wang, et al.
MedComm (2024) Vol. 5, Iss. 7
Open Access | Times Cited: 1
The Effect of Diabetes Mellitus Type 1 on the Energy Metabolism of Hepatocytes: Multiphoton Microscopy and Fluorescence Lifetime Imaging
Svetlana Rodimova, Nikolai Bobrov, Artem M Mozherov, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 17016-17016
Open Access | Times Cited: 3
Oxymatrine Alleviates High-Fat-High-Fructose-Induced Fatty Liver in Rats: Understanding the Molecular Mechanism Through an Untargeted Metabonomics Study
Huan Li, Chang Wang, Qing Wang, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 4013-4024
Open Access | Times Cited: 3
Loss of endothelial glucocorticoid receptor accelerates organ fibrosis indb/dbmice
Swayam Prakash Srivastava, Julie E. Goodwin
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top